[PDF][PDF] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene …
A Inoue, T Suzuki, T Fukuhara, M Maemondo… - J Clin …, 2006 - researchgate.net
A Inoue, T Suzuki, T Fukuhara, M Maemondo, Y Kimura, N Morikawa, H Watanabe, Y Saijo…
J Clin Oncol, 2006•researchgate.netProspective Phase II Study of Gefitinib for Chemotherapy- Naıve Patients With Advanced
Non–Small-Cell Lung Cancer With Epider Page 1 Prospective Phase II Study of Gefitinib for
ChemotherapyNaıve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal
Growth Factor Receptor Gene Mutations Akira Inoue, Takuji Suzuki, Tatsuro Fukuhara, Makoto
Maemondo, Yuichiro Kimura, Naoto Morikawa, Hiroshi Watanabe, Yasuo Saijo, and Toshihiro
Nukiwa A B S T R A C T Purpose This study was undertaken to investigate the efficacy and …
Non–Small-Cell Lung Cancer With Epider Page 1 Prospective Phase II Study of Gefitinib for
ChemotherapyNaıve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal
Growth Factor Receptor Gene Mutations Akira Inoue, Takuji Suzuki, Tatsuro Fukuhara, Makoto
Maemondo, Yuichiro Kimura, Naoto Morikawa, Hiroshi Watanabe, Yasuo Saijo, and Toshihiro
Nukiwa A B S T R A C T Purpose This study was undertaken to investigate the efficacy and …
Purpose
This study was undertaken to investigate the efficacy and the feasibility of gefitinib for chemotherapy-naıve patients with advanced non–small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations.
researchgate.net